Bank of America’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-42
| Closed | -$84 | – | 8213 |
|
|
2023
Q1 | $84 | Buy |
42
+37
| +740% | +$110 | ﹤0.01% | 7493 |
|
|
2022
Q4 | $18 | Sell |
5
-16
| -76% | -$68 | ﹤0.01% | 8007 |
|
|
2022
Q3 | $0 | Sell |
21
-58
| -73% | -$412 | ﹤0.01% | 8457 |
|
|
2022
Q2 | $0 | Sell |
79
-88
| -53% | -$821 | ﹤0.01% | 8702 |
|
|
2022
Q1 | $2K | Sell |
167
-710
| -81% | -$9.05K | ﹤0.01% | 8072 |
|
|
2021
Q4 | $13K | Sell |
877
-512
| -37% | -$10.8K | ﹤0.01% | 7649 |
|
|
2021
Q3 | $33K | Buy |
1,389
+1,145
| +469% | +$34.4K | ﹤0.01% | 7231 |
|
|
2021
Q2 | $9K | Sell |
244
-1,214
| -83% | -$48.3K | ﹤0.01% | 7336 |
|
|
2021
Q1 | $70K | Buy |
1,458
+946
| +185% | +$54.8K | ﹤0.01% | 6523 |
|
|
2020
Q4 | $25K | Buy |
512
+157
| +44% | +$5.91K | ﹤0.01% | 6541 |
|
|
2020
Q3 | $13K | Sell |
355
-407
| -53% | -$22.9K | ﹤0.01% | 6391 |
|
|
2020
Q2 | $52K | Sell |
762
-680
| -47% | -$27.1K | ﹤0.01% | 5968 |
|
|
2020
Q1 | $34K | Sell |
1,442
-567
| -28% | -$13.6K | ﹤0.01% | 6007 |
|
|
2019
Q4 | $31K | Buy |
+2,009
| New | +$26.7K | ﹤0.01% | 6407 |
|
|
2019
Q3 | – | Sell |
-7,111
| Closed | -$56K | – | 7618 |
|
|
2019
Q2 | $56K | Buy |
7,111
+7,107
| +177,675% | +$72.3K | ﹤0.01% | 6264 |
|
|
2019
Q1 | $0 | Sell |
4
-646
| -99% | -$7.49K | ﹤0.01% | 7522 |
|
|
2018
Q4 | $5K | Sell |
650
-2,254
| -78% | -$39.5K | ﹤0.01% | 6777 |
|
|
2018
Q3 | $68K | Buy |
2,904
+2,739
| +1,660% | +$104K | ﹤0.01% | 6069 |
|
|
2018
Q2 | $8K | Buy |
165
+26
| +19% | +$1.29K | ﹤0.01% | 6717 |
|
|
2018
Q1 | $6K | Sell |
139
-1,104
| -89% | -$55.4K | ﹤0.01% | 6745 |
|
|
2017
Q4 | $57K | Sell |
1,243
-813
| -40% | -$43.1K | ﹤0.01% | 6013 |
|
|
2017
Q3 | $127K | Buy |
2,056
+675
| +49% | +$39.5K | ﹤0.01% | 5580 |
|
|
2017
Q2 | $87K | Sell |
1,381
-290
| -17% | -$16.1K | ﹤0.01% | 5654 |
|
|
2017
Q1 | $125K | Buy |
1,671
+1,313
| +367% | +$146K | ﹤0.01% | 5523 |
|
|
2016
Q4 | $53K | Buy |
358
+343
| +2,287% | +$60.7K | ﹤0.01% | 5903 |
|
|
2016
Q3 | $3K | Sell |
15
-26
| -63% | -$4.78K | ﹤0.01% | 6755 |
|
|
2016
Q2 | $8K | Buy |
+41
| New | +$8.93K | ﹤0.01% | 6580 |
|
Bank of America's NH Position: Q2 2023 in Review
Bank of America sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 42 shares — an estimated $84 sold.
Bank of America first reported a position in NH in Q2 2016 and held it in 27 quarters. The position peaked at $127K in Q3 2017. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- Bank of America reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- Bank of America sold 42 NantHealth, Inc shares in Q2 2023, an estimated $84.
- Bank of America first reported a position in NantHealth, Inc in Q2 2016 and held it in 27 quarters.
- Bank of America's NantHealth, Inc position peaked at $127K in Q3 2017.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on Bank of America's 13F filing for Q2 2023, filed 14 Aug 2023.